MedCity News January 22, 2024
Ron Harman King

No matter the outcome, it’s certain that the cost of drugs will not be an issue easily resolved anytime soon even though several other states also have laws allowing for drug imports.

On January 5, the U.S. Food and Drug Administration (FDA) authorized the state of Florida to import medications from Canada in a measure to lower prices for the state’s residents. To no one’s surprise, the pharmaceutical industry has greeted the news as though it were another sub-zero arctic blast sweeping down from the Canadian prairies.

The American Society of Health-System Pharmacists (ASHSP) labeled the effort futile, saying that the “Canadian market cannot supply anywhere close to the amount of medication needed to bring down U.S. drug prices.”

Further,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, States
Nevada announces intent to award Medicaid contracts
Where Medicaid Budget Cuts Would Hit Hardest
Trump blesses Medicaid scrutiny to pay for mega-MAGA package
OpenAI calls for US to centralize AI regulation
Expanded Medicare Coverage of Intensive Outpatient Services: Considerations for States

Share This Article